Komen Researcher Alex Cheng is...

Komen grantee Alex Cheng is working to determine the overall burden on patients of breast cancer treatment so they can......

Women’s Health Week: How Lifestyle...

Maintaining a healthy lifestyle can provide many benefits, including the potential to lower a person's risk of developing breast cancer....

Identifying Biomarkers in Breast Cancer...

Komen Researcher Dr. Aileen Fernandez says identifying persons who don’t respond to treatments can be just as important as finding......

What are biosimilars?

Biosimilars are FDA-approved drugs that are “highly similar” to an existing biologic drug. A common biologic used to treat HER2-positive......

Biosimilars May Give Doctors More...

The approval of more treatment options for MBC gives doctors, and patients, more tools and options to use in patient......

Past Clinical Trials Pave The...

New medicines and therapies to treat some of the most complicated diseases are available because of years of research and......

What Snapped Links Can Tell...

The issue of treatment resistance has confounded researchers for years and is a question that Svasti Haricharan, Ph.D, and her......

Komen Researcher Dr. Jennifer Rosenbluth...

Dr. Jennifer Rosenbluth specializes in inflammatory breast cancer, an uncommon but deadly subtype of breast cancer....

Genetics Helps Us Better Understand...

A look at genetics and history can help us understand who is at greater risk of developing breast cancer so......

Training the Next Generation of...

Trainees in Komen's Training Breast Cancer Researchers to Eliminate Disparities (TREND) program presented work and participated in discussions about improving......

Research on Hard-To-Treat Cancers, Brinker...

Komen-funded research and updates presented at SABCS show there are new treatment options for breast cancers....

Disparities Research Conference Focuses on...

Susan G. Komen virtually gathered leading experts and advocates in academia, philanthropy and industry to address breast cancer disparities....